EUTM file information

001872886

GENEBLAZER


September 25, 2000

Trademark Summary

The trademark application GENEBLAZER was filed by Life Technologies Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 20, 2001, and it was registered by office on October 22, 2001 without any oppositions.

The application was filed in English (Spanish was selected as the second language).

Two renewals of the trademark were recorded, one on September 21, 2010, and the other one on April 6, 2020.

A transfer of the trademark registration was recorded on May 20, 2007. A transfer of the trademark registration was recorded on August 26, 2007. Appointment and Replacement of representative of the trademark registration was recorded on October 7, 2007. Change of name and address of the trademark registration was recorded on June 7, 2009. A transfer of the trademark registration was recorded on June 7, 2009. Creation of rights in rem of the trademark registration was recorded on February 7, 2010. Cancellations of entries of the trademark registration was recorded on July 5, 2010. Change of name and address of the trademark registration was recorded on August 8, 2010. Deletion of the representative of the trademark registration was recorded on November 1, 2010. Change of name and professional address of the trademark registration was recorded on July 17, 2012. Change of name and professional address of the trademark registration was recorded on May 5, 2013. Change of name and professional address of the trademark registration was recorded on May 5, 2014. Appointment and Replacement of representative of the trademark registration was recorded on January 4, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 28, 2021.


Goods And Services

  • The mark was filed in class 1 with Reagents and assays for scientific and research laboratory use in biological, chemical and environmental testing and for the screening of compounds.
  • The mark was filed in class 5 with Diagnostic reagents and assays for clinical medical laboratory use in biological, chemical and environmental testing and for the screening of compounds.
  • The mark was filed in class 42 with Pharmaceutical research and development services, assay and screen development, compound screening, compound and chemical identification, and drug target identification and characterization.